Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Massachusetts' Individual Mandates, Insurance Exchanges Are Examples For National Plan
"Three years into its experiment with near-universal health care, Massachusetts has some "dos and don"ts" for the nation as it grapples with the best way to cover tens of millions of uninsured Americans," the Associated Press reports. "Do require that virtually everyone have health insurance, the overriding goal in Massachusetts. Don"t ignore rising costs, the single greatest threat to the law"s long-term affordability."
generic viagra online
GM, UAW Nearing Deal To Use Company Stock For Half Of VEBA Obligation, s Say
General Motors and the United Auto Workers are close to finalizing a deal that would reduce the automaker"s cash obligation to a retiree health care trust fund, according to people with knowledge of the matter, the Wall Street Journal reports. UAW in 2007 agreed to establish the voluntary employees" beneficiary association, totaling $35 billion, that would cover health care costs of retired GM workers and their spouses starting in 2010. GM has paid about $15 billion into the fund, but under the deal now being discussed, the remaining $20 billion obligation could be paid using about $10 billion in cash and a 39% equity stake in the restructured GM that will be formed under the Treasury Department"s "controlled bankruptcy" plan for the firm. The deal would be subject to approval by UAW"s 60,000 GM members, who likely would face "steep cuts" in pay and benefits as a result, as well as 20,000 additional layoffs, according to the Journal. Union officials also have expressed concern that the GM stock making up the equity stake is "illiquid and hard to value, posing a big risk for UAW members," the Journal reports. GM and UAW could agree to a final version of the deal "as early as next week," according to the Journal (Stoll, Wall Street Journal, 5/15). Chrysler
News of the day
Preimplantation Genetic Diagnosis May Pose Neurological Risks
Preimplantation genetic diagnosis (PGD) has helped many couples conceive healthy children and is generally considered a safe practice. However, a new long-term analysis of PGD in mice suggests that this procedure may increase risks of weight gain and memory decline in adulthood.
Diagnostics

Pharmalucence, Inc. Announces FDA Approval For Its Generic Sestamibi Kit

Pharmalucence, Inc., a leading supplier of radiopharmaceutical products, announced that it received approval from the U. S. Food and Drug Administration (FDA) Office of Generic Drugs for its Abbreviated New Drug Application (ANDA) to manufacture and market its Kit for the Preparation of Technetium Tc-99m Sestamibi Injection. The FDA has determined that Pharmalucence"s Sestamibi Kit is therapeutically equivalent to Cardiolite® 1, an imaging agent used in evaluating myocardial function and to detect coronary artery disease by localizing myocardial ischemia and infarction. The agent is also for use in breast imaging as a second line diagnostic after mammography to assist in the evaluation of breast lesions. Glenn Alto, President and CEO of Pharmalucence said, "When Pharmalucence was formed two years ago we committed to bring choice to the nuclear medicine community through an expanded line of radiopharmaceutical kits. The approval of our sestamibi kit marks the second generic imaging agent to emerge from the Pharmalucence Development team. Pharmalucence remains focused on delivering the products and enhancing the manufacturing assets that will provide nuclear medicine practitioners high quality imaging agents now and in the future." Pharmalucence will begin shipping their generic sestamibi kit on August 3. 1. Cardiolite® is a trademark of Lantheus Medical Imaging, Inc. Pharmalucence, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009